HoldiPharma company possesses 12 subsidiaries, and contributes in the capital of 12 companies. The committee will hold a hearing session with the leaders of the Medical Holding Company to set a development plan for the subsidiaries in the coming period. She added that providing medicine is a national security issue and the current situation is a result of the lack of vision and planning for medicine production in Egypt. El-Hamaky said that the crisis has been exacerbated due to the negligence of domestic medicine production; most raw materials are imported which allows private and foreign companies to control the medicine market. This hinders the market from benefiting from the Medicine Holding Company’s subsidiaries.

Source: Daily News Egypt November 23, 2016 15:33 UTC